| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria
|
Höglinger, Günter U
|
|
|
23 |
2 |
p. 191-204
|
article
|
| 2 |
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
|
Simuni, Tanya
|
|
|
23 |
2 |
p. 178-190
|
article
|
| 3 |
A chance to prevent Alzheimer's disease sooner than you think
|
Reiman, Eric M
|
|
|
23 |
2 |
p. 144-145
|
article
|
| 4 |
A multipronged approach to advancing palliative care for people with intellectual disabilities
|
Chan, Kwok Ying
|
|
|
23 |
2 |
p. 138
|
article
|
| 5 |
A multipronged approach to advancing palliative care for people with intellectual disabilities – Author's reply
|
Kluger, Benzi M
|
|
|
23 |
2 |
p. 138-139
|
article
|
| 6 |
Challenges and opportunities in spinal muscular atrophy therapeutics
|
Yeo, Crystal J J
|
|
|
23 |
2 |
p. 205-218
|
article
|
| 7 |
Correction to Lancet Neurol 2023; 22: 1089–91
|
|
|
|
23 |
2 |
p. e2
|
article
|
| 8 |
Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial
|
van Arnhem, Marleen M L
|
|
|
23 |
2 |
p. 147-156
|
article
|
| 9 |
Criteria for a biological definition of neuronal α-synuclein disease—a major conceptual step forward
|
Jack Jr, Clifford R
|
|
|
23 |
2 |
p. 129-130
|
article
|
| 10 |
Crystal Jing Jing Yeo
|
|
|
|
23 |
2 |
p. 143
|
article
|
| 11 |
Deciphering spinal muscular atrophy: the need for more research
|
Farrar, Michelle Anne
|
|
|
23 |
2 |
p. 134-136
|
article
|
| 12 |
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis
|
Chapleau, Marianne
|
|
|
23 |
2 |
p. 168-177
|
article
|
| 13 |
Has the time come to redefine Parkinson's disease?
|
Darweesh, Sirwan K L
|
|
|
23 |
2 |
p. 130-133
|
article
|
| 14 |
I am what I am
|
De Ambrogi, Marco
|
|
|
23 |
2 |
p. 146
|
article
|
| 15 |
Parkinson's disease is a recognisable and useful diagnostic entity
|
Obeso, José A
|
|
|
23 |
2 |
p. 133-134
|
article
|
| 16 |
Parkinson's eponym
|
Weatherall, Mark
|
|
|
23 |
2 |
p. 143
|
article
|
| 17 |
Platelet glycoprotein VI inhibition: a promising therapeutic avenue in acute ischaemic stroke
|
Ganesh, Aravind
|
|
|
23 |
2 |
p. 125-127
|
article
|
| 18 |
Posterior cortical atrophy: new insights into treatments and biomarkers for Alzheimer's disease
|
Bejanin, Alexandre
|
|
|
23 |
2 |
p. 127-128
|
article
|
| 19 |
Rapid genome sequencing for infantile-onset epilepsy within a national health-care setting
|
Robinson, Hannah K
|
|
|
23 |
2 |
p. 139-140
|
article
|
| 20 |
Reducing the uses of valproate: a controversial decision
|
The Lancet Neurology,
|
|
|
23 |
2 |
p. 123
|
article
|
| 21 |
Rhonda Voskuhl: basketball and bedside to bench to bedside
|
Morgan, Jules
|
|
|
23 |
2 |
p. 142
|
article
|
| 22 |
Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial
|
Mazighi, Mikaël
|
|
|
23 |
2 |
p. 157-167
|
article
|
| 23 |
The AfrAbia+plus Parkinson's Disease Genomic Consortium
|
Mohamed, Wael
|
|
|
23 |
2 |
p. 140-141
|
article
|
| 24 |
The difficulties in treating children with rare epileptic encephalopathies
|
Karkare, Shefali
|
|
|
23 |
2 |
p. 124-125
|
article
|
| 25 |
Venglustat in GBA1-related Parkinson's disease
|
Zimran, Ari
|
|
|
23 |
2 |
p. 137
|
article
|
| 26 |
Venglustat in GBA1-related Parkinson's disease – Authors' reply
|
Sardi, S Pablo
|
|
|
23 |
2 |
p. 137-138
|
article
|
| 27 |
WHO considers multiple sclerosis treatments essential
|
Laurson-Doube, Joanna
|
|
|
23 |
2 |
p. 140
|
article
|
Journal description